SynthesisPharmacoEconomics2022

Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review.

Thitima Kongnakorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.